Key Takeaways
- International pivot delivers, domestic projects drag: International revenue doubled to INR1,133 crores and EBITDA rose to INR152 crores, while the Indian project business collapsed to INR92 crores in Q4 from INR253 crores a year ago, holding consolidated revenue flat.
- South Africa order book transforms the backlog: A ZAR400 crore order received post-March, taking PCI Africa's total order book to approximately INR3,100 crores, with margins described as "excellent" and execution ramping from H2 FY27.
- Jal Jeevan Mission Phase 2 is the domestic catalyst: Cabinet clearance in March unlocks a INR5 lakh crore balance investment over 30 months; INR300 crores in outstanding receivables are expected to start releasing this quarter, with tender momentum building by Q2.
- Margins hold the 15-20% band, mix shift helps: Consolidated EBITDA margin at 17.16% sits inside the normalized target range; higher-margin South African projects and a growing international revenue share (60-65% target) point toward enhancement.
- What to watch next quarter: Whether Jal Jeevan receivables actually start flowing, the pace of South African project mobilization, and any concrete acquisition announcement after the authorized capital increase.
International Business: The Growth Engine
- Revenue doubled, profitability followed: International revenues rose from INR668 crores to INR1,133 crores and EBITDA from INR88 crores to INR152 crores, with PCI Africa contributing only 9-10 months after a mid-year acquisition.
- South Africa is the new anchor: PCI Africa holds an order book of approximately INR3,100 crores, including a ZAR400 crore order received after 31st March and reported in May; the Maccasar and Lower Umkhomazi projects from the City of Cape Town provide healthy medium-term revenue visibility.
- Execution timeline is clear: Projects will move into engineering and execution now, with revenue momentum visible from the second half of FY27 and peak revenues arriving in year two as a thumb rule; the entire order book is to be executed over the next 3 to 4 years.
- Project quality is structurally better: These are high-end process-related businesses involving water reuse and complex wastewater projects with less pipeline or low-end civil work, run by a 100-year-old company with strong systems and well-planned 3-4 year timeframes.
- Thailand JV delivered a standout year: Surpassed INR300 crores in revenue for the first time during FY26, up from INR50 crores during COVID.
- Gruppo Aturia, Sterling and United, Eigenbau all firing: Aturia saw strong MENA order inflows from oil and gas and water; Australia benefited from LNG and mining demand; Eigenbau South Africa recorded its best-ever revenue and profitability.
- Forex tailwind material: Rupee depreciation of over 11% was a big gain, with an INR139 crore exchange difference reflected in the consolidated balance sheet.
Prakash Agarwal: "Margins are excellent and contractual periods are very good 4 years, 3 years, they get. So, I think it's completely -- it's a very big positive and learning for us, and we are very excited about how it will play out."
Domestic Business: A Tale of Two Divisions
- Product division held its ground: Q4 revenues were flat at INR109 crores versus INR108 crores, with healthy order booking momentum and an improving backlog; overall Indian product grew 15% for the year, driven by power, industrial and water sector demand.
- Project division collapsed in Q4: Revenues fell to INR92 crores from INR253 crores a year ago as the company focused on project commissioning and O&M commencement; employee costs rose to INR78 crores against lower revenue because sites must be manned even when revenue recognition lags.
- Jal Jeevan Mission Phase 2 resets the outlook: Cabinet clearance came in March with an enhanced outlay, a 30-month timeline ending December 2028, and a balance investment of close to INR5 lakh crores; management expects tender momentum to build by Q2 FY27, with a big requirement visible by H2.
- Receivables recovery is the near-term trigger: Approximately INR300 crores in Jal Jeevan receivables are outstanding; no money has been received yet, but management is confident of very good fund release starting this month and increasing next month.
- Pipeline is thin right now: Management acknowledged the domestic project pipeline is "quite low" presently and declined to quantify expected order inflow, saying it is better to wait and watch.
- O&M transition underway: Several projects have moved into O&M or defect liability/O&M transition; FY27 will see the first impact of reasonable O&M revenue, though no current-year figure was provided.
Prakash Agarwal: "The point we're trying to highlight on the Jal Jeevan is that there is a positive news in the Jal Jeevan, which supports the outlook for the future. Similarly, South Africa, the orders, which we expected have come and it strengthens our outlook for the future. But all our businesses are performing."
Margins: In the Band, With Upside
- Consolidated margin held the target range: EBITDA margin improved to 17.16% for FY26, within the normalized 15-20% band management targets.
- Domestic operations already above the band: Domestic operations delivered 21% EBITDA this year, suggesting the consolidated number is dragged down by international mix that is still scaling.
- South Africa carries structurally higher margins: Management described South African project margins as "excellent" and much higher than Indian project business, which implies a positive mix shift as PCI Africa revenue scales from H2 FY27.
- Gross margin fluctuates by mix: Margins vary between products, projects and countries; management pointed to the overall year-end range of 15-20% EBITDA as the right lens.
- Employee cost spike is project-lag, not structural: Q4 employee costs at INR78 crores on INR511 crores revenue (versus INR60 crores on INR572 crores last year) reflect sites being manned while revenue recognition lags, a timing issue that reverses as execution catches up.
- Raw material volatility is a watchpoint: Stainless steel has become expensive with most imports coming from the Gulf; management described it as volatile rather than a steady rising curve and declined to draw conclusions.
Capital Allocation & Strategic Moves
- Authorized capital increase signals acquisition appetite: The board passed an enabling resolution to pursue acquisitions; management believes the environment is positive for getting good strategic assets at reasonable valuations and is actively exploring targets in the product space, hoping for results soon.
- U.S. market entry on the roadmap: The inorganic strategy involves acquiring a front-end presence in the U.S. and supporting it with engineering and manufacturing resources from other subsidiaries; Saudi Arabia market reach is also being explored.
- NSE listing awaits a fundraise: The company has not yet applied for an NSE listing because a capital-related condition cannot be met until funds are raised; management hopes to apply soon after raising funds.
- Tax litigation on Rutschi sale proceeds: Appeals have been filed and advisers are confident of a positive result, expected in approximately 18 months, though management cannot assure money will flow in.
- Capex needs are minimal: Only small brownfield additions are needed for Indian product growth capacity.
- Trade receivables are a Jal Jeevan story: The major reason for the increase is unreleased Jal Jeevan Mission funds; total clear receivables overdue are roughly INR350 crores, with the rest invoiced and in process.
Prakash Agarwal: "I think the points I would like to say is that we look at it as a zero-sum game. So, in the zero-sum game, the first is the Jal Jeevan was a weakness for us, which we see as a positive going forward." [18-19]
Product Business & Other Geographies
- Product business grew 10% overall: Indian product grew 15%, international product grew 5%, and the backlog has improved across the board.
- Power and Jal Jeevan drive domestic product demand: Strong demand from the power sector, combined with the rollout of Jal Jeevan Mission Phase 2, is expected to support continued product growth.
- European demand was postponed, not lost: Geopolitical issues delayed European product demand, but management expects it to concretize now.
- Australia is the strongest player in mining and LNG: Sterling and United are benefiting from sustained momentum with huge investments planned in the Australian market.
- MISA Italy turned the corner: Successfully completed all legacy projects and is now witnessing a healthy pipeline of new irrigation and drainage-related opportunities.
- Large cooling water pump contracts secured: Wins from DVC and Deepak Chemicals strengthen the presence in power and industrial segments.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Jal Jeevan receivable recovery | ~INR300 cr outstanding to start releasing | Starting Q1 FY27, increasing over next couple of months |
| South Africa revenue ramp | Projects move to engineering and execution; momentum visible | From H2 FY27 |
| South Africa order book execution | Entire INR3,100 cr order book executed; peak revenues in year two | Next 3 to 4 years |
| Jal Jeevan Phase 2 tender momentum | Big requirement expected; process restarted positively | By Q2 FY27, with large requirement by H2 FY27 |
| O&M revenue impact | First impact of reasonable O&M revenue | FY27 |
| International revenue share | 60% to 65% of consolidated revenue | Going forward |
| EBITDA margin range | 15% to 20% normalized; currently ~17% | Ongoing |
| Acquisitions in product space | Actively exploring; hope to have results | Soon |
| Tax refund on Rutschi sale | Appeals filed; advisers confident of positive result | ~18 months (not assured) |
| NSE listing application | Hope to apply after raising funds | After fundraise |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Consolidated revenue | ₹511 cr, -11% YoY |
| Consolidated EBITDA margin | 14.9%, down from 20% in Q4 FY25 |
| Consolidated PBT | ₹67 cr, vs ₹65 cr in Q4 FY25 |
| Consolidated PAT from continuing ops | ₹47 cr, flat YoY; PAT margin 9.11% |
| Standalone revenue | ₹201 cr, -44% YoY |
| Standalone EBITDA margin | 25.03% |
| Standalone net profit | ₹40 cr, -13% YoY; PAT margin 19.98% |
| Domestic product division revenue | ₹109 cr, vs ₹108 cr in Q4 FY25 |
| Domestic project business revenue | ₹92 cr, vs ₹253 cr in Q4 FY25 |
| Consolidated gross margin | 71%, down from 76% in Q4 FY25 |
| Consolidated employee cost | ₹78 cr, vs ₹60 cr in Q4 FY25 on revenue of ₹572 cr |
| Consolidated trade receivables | ₹1,184 cr as of Mar '26, up from ₹820 cr in Mar '25 |
| Total order book | ~₹6,000 cr as of May 2026 |
| Product division order backlog | ₹579.6 cr as of Mar '26 |
| Project order book (as per presentation) | ₹3,900 cr as of Mar '26 |
| South Africa order book | ZAR 400 cr as of May 2026 |
| JJM order backlog | ~₹1,100 cr as of Q1 FY27 |
| O&M order book component | ~₹530 cr |
| International revenue (FY26) | ₹1,136 cr, up from ₹668 cr in FY25 |
| International EBITDA (FY26) | ₹152 cr, up from ₹88 cr in FY25 |
| India EBITDA margin (FY26) | 21% |
| International EBITDA margin (FY26) | 13% |
| Consolidated product business margin (FY26) | 22% |
| Forex gain (exchange difference, FY26) | ₹139 cr in consolidated balance sheet |
| Overdue JJM receivables | ~₹350 cr |